ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 225 filers reported holding ALKERMES PLC in Q2 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,716,670 | +8.0% | 593,000 | 0.0% | 4.66% | -2.5% |
| Q4 2022 | $15,483,230 | +16.9% | 593,000 | 0.0% | 4.78% | +12.6% |
| Q3 2022 | $13,248,000 | -74.0% | 593,000 | +38938.8% | 4.25% | +698.5% |
| Q2 2022 | $51,000,000 | +4523.8% | 1,519 | -96.6% | 0.53% | +82.8% |
| Q2 2021 | $1,103,000 | +47.3% | 45,000 | -13.5% | 0.29% | -14.7% |
| Q1 2020 | $749,000 | -52.7% | 52,000 | -25.7% | 0.34% | -41.9% |
| Q2 2019 | $1,582,000 | -81.4% | 70,000 | -70.0% | 0.59% | -81.3% |
| Q1 2019 | $8,502,000 | – | 233,000 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |